Work

Venetoclax in biomarker‐selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety

Year: 2023

Type: article

Source: Hematological Oncology

DOI: 10.1002/hon.3222

Authors: Mohamed Badawi, Sheryl Coppola, Doerthe Eckert, Sathej Gopalakrishnan, Benjamin Engelhardt, Eva Doelger, Weize Huang, Edyta Dobkowska, Shaji Kumar, Rajeev M. Menon, Ahmed Hamed Salem

Institutions: AbbVie (United States), AbbVie (Germany), Genentech, Mayo Clinic, Ain Shams University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AbbVie, Genentech

OpenAlex ID: W4386986647

FWCI: 1.244

Cites: 26

Cited by: 7

Related to: 10